128 related articles for article (PubMed ID: 26214642)
1. Prognostic value of vascular endothelial growth factor expression in women with ovarian cancer: A meta-analysis.
Hui G; Meng M
J BUON; 2015; 20(3):870-8. PubMed ID: 26214642
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis.
Yu L; Deng L; Li J; Zhang Y; Hu L
Gynecol Oncol; 2013 Feb; 128(2):391-6. PubMed ID: 23142075
[TBL] [Abstract][Full Text] [Related]
4. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
5. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
6. Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study.
Jewell EL; Darcy KM; Hutson A; Lee PS; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Dec; 115(3):424-9. PubMed ID: 19767063
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.
Zang J; Li C; Zhao LN; Shi M; Zhou YC; Wang JH; Li X
Head Neck; 2013 Oct; 35(10):1507-14. PubMed ID: 22987573
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein expression as a prognostic factor in ovarian cancer: a systematic review and meta-analysis.
Wu Y; Lu M; Zhou Q
J BUON; 2015; 20(3):855-61. PubMed ID: 26214640
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
Secord AA; Darcy KM; Hutson A; Lee PS; Havrilesky LJ; Grace LA; Berchuck A;
Gynecol Oncol; 2007 Jul; 106(1):221-32. PubMed ID: 17481705
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis.
Zhang J; Liu J; Zhu C; He J; Chen J; Liang Y; Yang F; Wu X; Ma X
Oncotarget; 2017 Apr; 8(15):24797-24803. PubMed ID: 28177889
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients.
Kassim SK; El-Salahy EM; Fayed ST; Helal SA; Helal T; Azzam Eel-D; Khalifa A
Clin Biochem; 2004 May; 37(5):363-9. PubMed ID: 15087251
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab.
Smerdel MP; Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
Gynecol Oncol; 2010 Aug; 118(2):167-71. PubMed ID: 20471067
[TBL] [Abstract][Full Text] [Related]
13. The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.
Skirnisdottir I; Seidal T; Åkerud H
Int J Oncol; 2016 Mar; 48(3):998-1006. PubMed ID: 26783205
[TBL] [Abstract][Full Text] [Related]
14. Association of reduced immunohistochemical expression of E-cadherin with a poor ovarian cancer prognosis--results of a meta-analysis.
Peng HL; He L; Zhao X
Asian Pac J Cancer Prev; 2012; 13(5):2003-7. PubMed ID: 22901162
[TBL] [Abstract][Full Text] [Related]
15. ErbB-3 predicts survival in ovarian cancer.
Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of vascular endothelial growth factor expression in patients with prostate cancer: a systematic review with meta-analysis.
Wang K; Peng HL; Li LK
Asian Pac J Cancer Prev; 2012; 13(11):5665-9. PubMed ID: 23317235
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density as a prognostic factor in ovarian cancer: a systematic review and meta-analysis.
He L; Wang Q; Zhao X
Asian Pac J Cancer Prev; 2015; 16(3):869-74. PubMed ID: 25735375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
